Systematic review of reduced therapy regimens for children with low risk febrile neutropenia
- 13 January 2016
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 24 (6) , 2651-2660
Abstract
Purpose Reduced intensity therapy for children with low-risk febrile neutropenia may provide benefits to both patients and the health service. We have explored the safety of these regimens and the effect of timing of discharge. Methods Multiple electronic databases, conference abstracts and reference lists were searched. Randomised controlled trials (RCT) and prospective observational cohorts examining the location of therapy and/or the route of administration of antibiotics in people younger than 18 years who developed low-risk febrile neutropenia following treatment for cancer were included. Meta-analysis using a random effects model was conducted. I 2 assessed statistical heterogeneity not due to chance. Registration: PROSPERO (CRD42014005817). Results Thirty-seven studies involving 3205 episodes of febrile neutropenia were included; 13 RCTs and 24 prospective observational cohorts. Four safety events (two deaths, two intensive care admissions) occurred. In the RCTs, the odds ratio for treatment failure (persistence, worsening or recurrence of fever/infecting organisms, antibiotic modification, new infections, re-admission, admission to critical care or death) with outpatient treatment was 0.98 (95% confidence interval (95%CI) 0.44–2.19, I 2 = 0 %) and with oral treatment was 1.05 (95%CI 0.74–1.48, I 2 = 0 %). The estimated risk of failure using outpatient therapy from all prospective data pooled was 11.2 % (95%CI 9.7–12.8 %, I 2 = 77.2 %) and using oral antibiotics was 10.5 % (95%CI 8.9–12.3 %, I 2 = 78.3 %). The risk of failure was higher when reduced intensity therapies were used immediately after assessment, with lower rates when these were introduced after 48 hours. Conclusions Reduced intensity therapy for specified groups is safe with low rates of treatment failure. Services should consider how these can be acceptably implemented.Keywords
Funding Information
- Candlelighters Clinical Research Fellow
This publication has 42 references indexed in Scilit:
- Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile NeutropeniaPLOS ONE, 2012
- Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patientsSupportive Care in Cancer, 2012
- Barriers to rehabilitative care for young breast cancer survivors: a qualitative understandingSupportive Care in Cancer, 2011
- Cost-effectiveness of Outpatient Management for Febrile Neutropenia in Children With CancerPediatrics, 2011
- Randomized Control Trial Comparing Oral Amoxicillin-clavulanate and Ofloxacin With Intravenous Ceftriaxone and Amikacin as Outpatient Therapy in Pediatric Low-risk Febrile NeutropeniaJournal of Pediatric Hematology/Oncology, 2009
- Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropeniaPediatric Blood & Cancer, 2007
- Outpatient, sequential, parenteral‐oral antibiotic therapy for lower risk febrile neutropenia in children with malignant diseaseCancer, 2003
- Oral Cefixime Is Similar to Continued Intravenous Antibiotics in the Empirical Treatment of Febrile Neutropenic Children with CancerClinical Infectious Diseases, 2001
- A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremiaThe Journal of Pediatrics, 1996
- Emperical Oral Antibiotic Therapy for Children with Low Risk Febrile Neutropenia during Cancer ChemotherapyJournal of Nepal Paediatric Society, 1970